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Serine phosphorylation and maximal activation of STAT3 during
CNTF signaling is mediated by the rapamycin target mTOR
Kiyotaka Yokogami*, Shinichiro Wakisaka†, Joseph Avruch‡
and Steven A. Reeves*
Neuropoietic cytokines such as ciliary neurotrophic factor
(CNTF) can activate multiple signaling pathways in
parallel, including those involving Janus kinase
(JAK)–signal transducers and activators of transcription
(STATs) [1], mitogen-activated protein kinase (MAPK) [2],
phosphatidylinositol 3-kinase (PI 3-kinase) and
mammalian target of rapamycin (mTOR)–p70 S6 kinase
[3]. Crosstalk occurs between these pathways, because
studies have shown that STAT3 requires phosphorylation
on tyrosine and serine residues by independent protein
kinase activities for maximal activation of target gene
transcription [4]. Members of the JAK/Tyk family of
tyrosine kinases mediate phosphorylation of STAT3 at
Tyr705 during CNTF signaling; however, the kinase
responsible for phosphorylation at STAT3 Tyr727 appears
to depend on both the extracellular stimulus and the
cellular context [5–8]. Here we investigate the kinase
activity responsible for phosphorylation of STAT3 on
Ser727 in CNTF-stimulated neuroblastoma cells. We
found that CNTF-induced phosphorylation of Ser727 was
inhibited by the mTOR inhibitor rapamycin, but not by
inhibitors of MAPK and protein kinase C (PKC) activation.
A STAT3 peptide was efficiently phosphorylated on
Ser727 in a CNTF-dependent manner by mTOR, but not
by a kinase-inactive mTOR mutant or by p70 S6 kinase. In
agreement with these biochemical studies, rapamycin
treatment of cells transfected with a STAT-responsive
promoter reporter decreased activation of the reporter to
the same degree as a STAT3 Ser727Ala mutant. The
ability of mTOR to contribute to activation of STAT3
extends the function of mTOR [9] in mammalian cells to
include transcriptional regulation.
Addresses: *Molecular Neuro-Oncology, Neurosurgical Service,
Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts 02129, USA. †Department of Neurosurgery, Miyazaki
Medical College, Miyazaki 889-1601, Japan. ‡Diabetes Unit and
Medical Services and Department of Molecular Biology,
Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts 02129, USA.
Correspondence: Steven A. Reeves
E-mail: reeves@helix.mgh.harvard.edu
Received: 2 August 1999
Revised: 24 November 1999
Accepted: 24 November 1999
Published: 17 December 1999
Current Biology 2000, 10:47–50
0960-9822/00/$ – see front matter 
© 2000 Elsevier Science Ltd. All rights reserved.
Results and discussion
The CNTF-related cytokine LIF has been shown to acti-
vate the mTOR/p70 S6 kinase/4E-BP1 pathway in cardiac
myocytes [3]. We therefore examined whether this
pathway mediated Ser727 phosphorylation of STAT3
during CNTF stimulation of human neuroblastoma NBFL
cells. Rapamycin has been shown to inhibit the mTOR
serine/threonine kinase, and the downstream mTOR
effectors p70 S6 kinase and 4E-BP1 [10]. Rapamycin treat-
ment of NBFL cells suppressed CNTF-induced phospho-
rylation of STAT3 on Ser727 to background levels as
measured by immunoblotting analysis using an antibody to
phospho(Ser727)-STAT3 and by the lack of the mobility
shift characteristic of STAT3 serine phosphorylation
(Figure 1a). Rapamycin treatment (5 ng/ml and 10 ng/ml)
also abolished CNTF-induced p70 S6 kinase activity
(Figure 1b) as well as the appearance of the phosphorylated
form of p70 S6 kinase (Figure 1c). We and others have pre-
viously shown that CNTF stimulation of NBFL cells
results in MAPK activation, leading to c-fos induction [2,11].
Treatment of CNTF-stimulated NBFL cells with
PD098059 or H7 (inhibitors of MAPK and PKC, respec-
tively) did not alter serine phosphorylation or migration of
STAT3 when compared with cells stimulated with CNTF
alone (Figure 1d,e). Downregulation of PKC by phorbol
12-myristate 13-acetate pretreatment also did not alter the
migration of STAT3 (data not shown). We confirmed that
the concentration of PD098059 and H7 used in these exper-
iments was sufficient to inhibit activation of MAPK and a
H7-sensitive kinase such as PKC by probing a filter with
anti-Fos antibody. CNTF-stimulated induction of c-fos was
completely blocked by 10 µM PD098059 and 100 µM H7
(Figure 1f). The MAPK family members SAPK/JNK and
p38 were not detectably activated in CNTF-stimulated
NBFL cells (data not shown). Thus the CNTF-activated
kinase that mediates Ser727 phosphorylation of STAT3 in
NBFL cells is either mTOR or a downstream kinase that is
activated by mTOR, such as p70 S6 kinase.
To examine whether mTOR or p70 S6 kinase can mediate
phosphorylation of STAT3 at Ser727 we immunoprecipi-
tated these kinases from CNTF-stimulated cells and sub-
jected the immunoprecipitates to in vitro kinase assays
using a STAT3 peptide corresponding to residues 720–731
(STAT3(720–731)). The purified fusion protein GST–4E-
BP1 and a S6 peptide were included as positive controls for
mTOR and p70 S6 kinase activity, respectively. A peptide
corresponding to the PKC recognition motif was used as a
negative control. We used human embryonic kidney cell
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line HEK293T in these experiments because these cells
respond to CNTF stimulation by activating JAK/STAT
and mTOR/p70 S6 kinase/4E-BP1 pathways, but not the
Ras/MAPK pathway. This is shown in the supplementary
figure where CNTF stimulation of HEK293T cells results
in Tyr705 and Ser727 phosphorylation of STAT3 (see Sup-
plementary material; Figure S1b), and Ser/Thr phosphory-
lation of p70 S6 kinase, which is inhibited by pretreatment
of the cells with rapamycin (Figure S1b). In contrast,
CNTF does not induce phosphorylation of MAPK or
increased levels of c-Fos (Figure S1c). HEK293T cells
were transfected with an expression vector encoding
hemagglutinin (HA)-tagged wild-type mTOR (mTOR-
WT) or kinase-inactive mTOR (mTOR-NK) [12], stimu-
lated with CNTF, and then immunoprecipitated with
anti-HA antibody. Immunoprecipitated mTOR-WT but
not mTOR-NK phosphorylated the STAT3(720–731)
peptide and GST–4E-BP1 protein to the same degree
(Figure 2a,b). There was no significant increase in phos-
phorylation of the PKC substrate peptide over that in
unstimulated cells. In addition, although endogenous p70
S6 kinase immunoprecipitated from CNTF-stimulated
cells efficiently phosphorylated the control S6 peptide, it
did not phosphorylate STAT3(720–731) to a greater
degree than observed in unstimulated cells (Figure 2c).
The consensus recognition motifs have been determined
for mTOR (Ser/Thr)-Pro [13] and p70 S6 kinase
(X–X–Arg/Lys–X–Arg–X–X–Ser–X–X; where X is any
amino acid) [14] and the motif recognized by mTOR is in
agreement with the Ser727–Pro728 region of STAT3. 
We next used a STAT-responsive luciferase reporter
(Cy1–Luc) containing the 180 base pair (bp) CyRE region
of the human VIP gene to examine the functional signifi-
cance of mTOR-mediated serine phosphorylation of
STAT3 (Figure 3a). Within the CyRE, two motifs have
been characterized that bind transcriptional complexes
made up of STAT dimers and AP-1 (composed of c-Fos
and JunB or JunD) [11] after CNTF treatment. A third
element contributing to full activation has recently been
identified at the 3′ end of the CyRE (A. Symes, personal
communication). All three motifs are required to achieve
maximal CNTF-induced transcription [11]. Transfection of
NBFL cells with the Cy1–Luc reporter followed by CNTF
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Figure 1
Activation of the mTOR/p70 S6 kinase/4E-BP1 pathway in CNTF
stimulated NBFL cells and rapamycin-sensitive phosphorylation of STAT3
at Ser727. (a) Total cell lysates from cells not treated (–) or pretreated
(+) with rapamycin (5 ng/ml) for 60 min and then stimulated with CNTF
for the indicated times were immunoblotted and probed with the
indicated antibody. The membrane was stripped and reprobed with
anti-ERK1 antibody to verify equal amounts of protein were loaded on the
gel. (b) CNTF-induced p70 S6 kinase activity was assessed with or
without rapamycin pretreatment. Each time point was performed in
triplicate. Data are expressed as mean ± SD. *p < 0.05 with reference to
the indicated comparisons. (c) Total cell lysates from (a) were
immunoblotted and probed with anti-p70 S6 kinase antibody.
(d,e) PD098059 (d) or H7 (e) do not inhibit serine phosphorylation of
STAT3 in NBFL cells. NBFL cells were either not treated (–) or pretreated
(+) with PD098059 (10 µM) or H7 (100 µM ) for 60 min. Cells were then
stimulated with CNTF for the indicated times. Equal amounts of lysate
were subjected to immunoblotting analysis and probed with indicated
antibodies. The membranes were then stripped and reprobed with anti-
STAT3 or anti-ERK1 antibody to verify that equal amounts of protein were
loaded on the gel. (f) Cells were pretreated with PD098059 or H7 and
processed as in (d,e) and lysates were immunoblotted and probed with
anti-Fos antibody. CT, empty expression vector as control.
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stimulation resulted in a ~40-fold increase in luciferase
activity compared with unstimulated cells (Figure 3b,
lanes 1,2); rapamycin pretreatment of the transfected cells
decreased the CNTF-stimulated increase in luciferase
activity to ~25-fold (Figure 3b, lane 3). Similarly, when a
STAT3 Ser727Ala mutant (STAT3-SA) was co-transfected
along with the Cy1–Luc reporter into NBFL cells, the
CNTF-stimulated increase in luciferase activity was also
decreased to ~25-fold (Figure 3b, lane 5). Pretreatment of
the STAT3-SA/Cy1–Luc transfected cells with rapamycin
did not result in a further decrease in the CNTF-stimulated
induction of luciferase activity (Figure 3b, lane 6). We con-
firmed that the concentration of rapamycin used in our
experiments specifically inhibited CNTF-stimulated mTOR
activity by transfecting NBFL cells with either mTOR-WT
or with a rapamycin-resistant mTOR mutant (mTOR-ST)
[12] in the absence or presence of rapamycin (Figure 3c). As
expected, in cells co-transfected with Cy1–Luc and mTOR-
WT, CNTF stimulated a ~40-fold increase in luciferase
activity; rapamycin pretreatment decreased the stimulatory
effect to ~18-fold (Figure 3c, lanes 1–3). However, in cells
co-transfected with the rapamycin-resistant mTOR-ST and
pretreated with rapamycin, CNTF-stimulated activation of
Cy1–Luc was restored to that observed in CNTF-stimu-
lated cells not pretreated (Figure 3c, lane 4). Thus these
data provide strong evidence that the protein kinase acti-
vated by CNTF and which mediates phosphorylation of
STAT3 at Ser727 is mTOR. 
In this study we identified mTOR as the serine kinase
that is necessary for full transcriptional activation of
STAT3 in CNTF-stimulated cells. mTOR (also known
as FRAP, RAFT or RAPT) is the mammalian homologue
of the yeast TOR1 and TOR2 proteins [9] and belongs to
a family of phosphatidylinositol kinase-related kinases
that includes ATM, MEC1, TEL1, RAD3 and MEI-41.
Members of this family have been shown to be involved
in a range of essential cell functions in yeast and mam-
malian cells, including cell-cycle progression, DNA
repair and DNA recombination [15]. Our data show that
mTOR phosphorylates STAT3 at Ser727 in a CNTF-
dependent manner in NBFL and HEK293T cells and
that this serine phosphorylation is required for STAT3 to
maximally activate transcription of a target gene. For
Brief Communication 49
Figure 2
In vitro phosphorylation of STAT3 at Ser727 by mTOR. (a) mTOR-
WT immunoprecipitated from CNTF-stimulated cells (black bars)
was used in an in vitro kinase assay with the indicated substrates.
Data points were performed in triplicate and are expressed as the
mean ± SD. (b) mTOR-WT or mTOR-NK immunoprecipitated from
CNTF-stimulated cells (black bars) were used in an in vitro kinase
assay with STAT3 peptide as a substrate. (c) p70 S6 kinase
immunoprecipitated from CNTF-stimulated cells (black bars) was
used in in vitro kinase assays with the indicated substrates. White
bars in (a–c) represent kinase activity immunoprecipitated from
unstimulated cells. *p < 0.05 compared with kinase activity from
cells not stimulated with CNTF.
Figure 3
CNTF-induced mTOR activation and Ser727 phosphorylation are
required for maximal activation of a STAT3-responsive reporter.
(a) Diagram of the STAT-responsive luciferase reporter construct
(Cy1–Luc) containing the 180 bp CyRE region of the human VIP gene.
The three elements indicated within the CyRE are required for full
induction of the reporter by CNTF (see text for details). (b) NBFL cells
were co-transfected with Cy1–Luc, and either an empty expression
vector (CT) or STAT3-SA. A pRSV–CAT (chloramphenicol
acetyltransferase) reporter construct was used as an internal control of
transfection efficiencies. Transfected cells were untreated or
pretreated with 5 ng/ml rapamycin for 1 h prior to stimulation with
CNTF. Luciferase activities were normalized to CAT activities.
*p < 0.05 versus mock-transfected cells with CNTF stimulation (lane
2). (c) NBFL cells were co-transfected with Cy1–Luc, pRSV–CAT,
and either HA–mTOR-WT or a rapamycin-resistant mutant HA–mTOR-
ST. *p < 0.05 versus mTOR-WT-transfected cells (lane 2). In all
transfections, results are the mean ± SD of three independent
experiments performed in duplicate.
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cytokines and growth factors to promote phenotypic
changes in mammalian cells they must coordinate activa-
tion of transcription with activation of the translation
apparatus. The ability of mTOR to contribute to activa-
tion of key components of the translation apparatus, p70
S6 kinase and 4E-BP1, as well as the transcription factor
STAT3, is an example of such coordination. Interest-
ingly, it has been reported recently that protein phos-
phatase 2A (PP2A) can regulate phosphorylation of
STAT3 on Ser727 [16], although it was not determined
whether PP2A accomplishes this directly or indirectly. It
is not likely that PP2A can directly dephosphorylate
STAT3 in our system, however, as we included a potent
inhibitor of PP2A (microcystin LR) in our mTOR kinase
assay. In addition, although there are reports that PP2A
and mTOR may be in the same pathway, it is controver-
sial whether PP2A is located upstream or downstream of
mTOR [17,18]. Further studies, therefore, are currently
underway to clarify these findings with regard to serine
phosphorylation of STAT3.
Materials and methods
Cell culture and transfection
NBFL cells and HEK293T cells were transfected with Cy1–Luc,
pRcCMV/STAT3 mutant SA (Ser727Ala) [4] (kindly provided by
J. Darnell), pCDNA1/HA-tagged wild-type mTOR, kinase-dead mTOR
mutant NK (Asn2343Lys) or the rapamycin-resistant mutant ST
(Ser2035Thr) [12], and pRSV–CAT. Transfected NBFL cells were
placed in serum-free medium for 24 h and then pretreated with
rapamycin and stimulated with CNTF (25 ng/ml). Lysates were prepared
12–24 h later and luciferase and CAT activities were assayed [2].
Cell lysis and immunoblotting
Standard procedures were used (see Supplementary material).
p70 S6 kinase assay
Assays were performed using a p70 S6 Kinase Assay kit (UBI, Lake
Placid, NY) according to the manufacturer’s recommendations. Sub-
strates used in the assays were S6 kinase substrate peptide (Ala–Lys–
Arg–Arg–Arg–Leu–Ser–Ser–Leu–Arg–Ala) or STAT3(720–731) peptide
(Asn–Thr–Ile–Asp–Leu–Pro–Met–Ser–Pro–Arg–Thr–Leu).
mTOR kinase assay
Assays were performed essentially as described previously [19]. 293T
cells were transfected with HA-tagged WT or NK mTOR [12], placed
in serum-free medium for 24 h and then stimulated with CNTF
(25 ng/ml). Lysates were precleared and immunoprecipitated with anti-
HA antibody. Immunoprecipitates were then used in mTOR kinase
assay with the following substrates: STAT3(720–731) peptide, PKC
substrate peptide (Glu–Lys–Arg–Pro–Ser–Gln–Arg–Ser–Lys–Tyr–Leu)
and GST–4E-BP1 protein.
Supplementary material
Supplementary material including experimental details of cell lysis and
immunoblotting is available at http://current-biology.com/supmat/sup-
matin.htm.
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